Replimune Group Inc

Replimune Group Inc

REPL

Get informed when a big investor buys or sells

+ Follow
Market Cap$922.56M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Replimune Group IncReplimune Group Inc-3.3--189%-0.2
$12.50

Target Price by Analysts

26.6% upsideReplimune Group Target Price DetailsTarget Price
$1.05

Current Fair Value

89.4% downside

Overvalued by 89.4% based on the discounted cash flow analysis.

Share Statistics

Market cap$922.56 Million
Enterprise Value$741.81 Million
Dividend Yield$- (-)
Earnings per Share$-3.38
Beta0.87
Outstanding Shares92,803,711

Return

Return on Equity-188.94%ROE
Return on Assets-94.45%
Return on Invested Capital-113.40%

Valuation & Multiples

P/E Ratio-3.25P/E Ratio
PEG264PEG
Price to Sales-Price to Sales
Price to Book Ratio9.87Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-2.39
Enterprise Value to Net Income-3
Total Debt to Enterprise0.04
Debt to Equity0.17Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
July 2, 2026
EPS Estimate
$-0.73
Average shareholder expectation
Revenue Estimate
$5.57 M
Average shareholder expectation

Next Earnings Call

Expected Date
July 30, 2026
EPS Estimate
$-0.63
Average shareholder expectation
Revenue Estimate
$13.60 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.0000 31.33%
Total Calls- 100.00%
Total Puts- 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %0.11% 87.86%
Total Invested$1.10M 99.82%
Investors Holding7 200.00%

ESG Score

No data

About Replimune Group Inc

CEO: Robert Coffin